AURKA is one of the downstream targets of MAPK1/ERK2 in pancreatic cancer
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
DUSP6/MKP-3, a specific inhibitor of MAPK1/ERK2, frequently loses its expression in primary pancreatic cancer tissues. This evidence suggests that constitutive activation of MAPK1 synergistically induced by frequent mutation of KRAS2 and the loss of function of DUSP6 plays key roles in pancreatic carcinogenesis and progression. By profiling of gene expressions associated with downregulation of MAPK1 induced by exogenous overexpression of DUSP6 in pancreatic cancer cells, we found that AURKA/STK15, the gene encoding Aurora-A kinase, which plays key roles in cellular mitosis, was among the downregulated genes along with its related genes, which included AURKB, TPX2 and CENPA. An association of expression and promoter activity of AURKA with MAPK activity was verified. Knockdown of ETS2 resulted in a reduction of AURKA expression. These results indicate that AURKA is a direct target of the MAPK pathway and that its overexpression in pancreatic cancer is induced by hyperactivation of the pathway, at least via ETS2.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“On one hand, aberrant activation of KRAS and downstream MAPK/ERK signaling promotes AURKA overexpression [129–131].”
From Differential Response and Resistance to KRAS-Targeted Therapy (2025) · cites this paper as [131]
Citations
Cites
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456 · cited 2×
“…residues (dTdT) overhanging at the 30 end to knock down the expressions of ETS2, ELK1 and LMNA, including 50-CAACAGGCUUGGAUUCCAU-30 for ETS2, 50-GGCAAUGGCCACAUCAUCU-30 for ELK1 and 50-CUGGACUUCCAGAAGAACA-30 for LMNA (Elbashir et al., 2001), were purchased from Japan Bioservice (Asaka, Japan).”
MethodProtein kinases and phosphatases: The Yin and Yang of protein phosphorylation and signaling
Hunter, T. (1995) · Cell · doi:10.1016/0092-8674(95)90405-0 · Cited by 2,950
Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation
Zhou, H., Kuang, J., Zhong, L., Kuo, W.-L., Gray, J., Sahin, A., Brinkley, B., & Sen, S. (1998) · Nature Genetics · doi:10.1038/2496 · Cited by 1,276 · cited 1×
“AURKA encodes AURKA/STK15/ Aurora-A kinase, which is an essential molecule involved in regulating the functions of centrosomes, spindles and kinetochores and is therefore required for proper mitosis of cells (Zhou et al., 1998; Marumoto et al., 2005).”
BackgroundWang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S. J., & Qin, J. (2000) · Genes & Development · doi:10.1101/gad.14.8.927 · Cited by 1,221
A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers
Bischoff, J. R. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3052 · Cited by 1,216 · cited 1×
“…is overexpressed in various cancer cells, including pancreatic cancer, and is associated with high-grade of tumors and poor survival of patients with cancer (Sen et al., 1997; Bischoff et al., 1998; Tanner et al., 2000; Miyoshi et al., 2001; Li et al., 2003; Jeng et al., 2004; Tong et al., 2004).”
BackgroundTargeting the mitogen-activated protein kinase cascade to treat cancer
Sebolt-Leopold, J. S., & Herrera, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1503 · Cited by 1,108
Protein phosphatases and the regulation of mitogen-activated protein kinase signalling
Keyse, S. M. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)00075-7 · Cited by 807 · cited 1×
“DUSP6 is a phosphatase strictly specific for MAPK1; it forms a feedback loop for physiological regulation of MAPK activity (Keyse, 2000).”
BackgroundAurora-A — A guardian of poles
Marumoto, T., Zhang, D., & Saya, H. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1526 · Cited by 697 · cited 5×
“2; however, an overexpression without gene amplification is also frequently observed (Marumoto et al., 2005).”
BackgroundInfluentialMolecular biology of the Ets family of transcription factors
Oikawa, T., & Yamada, T. (2003) · Gene · doi:10.1016/s0378-1119(02)01156-3 · Cited by 688 · cited 2×
“ETS2 is a transcription factor belonging to the ETS family of transcription factors (Oikawa and Yamada, 2003).”
BackgroundHunter, T., & Pines, J. (1991) · Cell · doi:10.1016/0092-8674(91)90028-w · Cited by 688 · cited 2×
“They included genes encoding cyclins such as CCNA2, CCNB1, CCNB2 and CCNE2 (Hunter and Pines, 1991), kinetocore-related molecules such as AURKA, AURKB, CENPA and CENPF (Hussein and Taylor, 2002; Kunitoku et al., 2003; Marumoto et al., 2005), microtubule-associated molecules such as TPX2 and KIF2C (Kufer et al., 2002;…”
Background
Cited by
Items 101–136 of 136
Aurora Kinase A Regulation by Cysteine Oxidative Modification
Lee, I., & Lee, B. (2023) · Antioxidants · doi:10.3390/antiox12020531 · Cited by 5
Zhou, X., Zhu, H., & Lu, J. (2014) · Europe PMC (PubMed Central) · Cited by 4
Kumari, P., & Tengli, A. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.144013 · Cited by 3
Oh, M., Kim, K., & Sun, H. (2020) · Journal of Bioinformatics and Computational Biology · doi:10.1142/s021972002050002x · Cited by 3
Chu, Z.-Y., & Zi, X.-J. (2024) · Pharmacological Research - Reports · doi:10.1016/j.prerep.2024.100010 · Cited by 4
Analyses of selected tumour-associated factors expression in normotensive and preeclamptic placenta
Balahmar, R. M., Ranganathan, B., Ebegboni, V. J., Alamir, J., Rajakumar, A., Deepak, V., & Sivasubramaniam, S. D. (2022) · Pregnancy Hypertension · doi:10.1016/j.preghy.2022.06.001 · Cited by 4
AURKA Enhances Antitumor Immunity by Activating CD4+ T Cell Proliferation in Colorectal Cancer
Xu, Y., Wang, W., Yu, J., Zhao, J., Dai, X., & Liu, Z. (2025) · Cancer Investigation · doi:10.1080/07357907.2025.2559403 · Cited by 3
Molecular Alterations in Pancreatic Cancer
Furukawa, T. (2017) · Springer eBooks · doi:10.1007/978-3-662-47181-4_2 · Cited by 1
Self-citationNoguchi, A., Kimura, M., Saiki, Y., Ishikawa, T., Kokumai, T., Omori, Y., Ono, Y., Miszukami, Y., Ishida, M., Mizuma, M., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-97166-1 · Cited by 1
“By comparing transcriptome profiles of human pancreatic cancer cells treated with and without mitogen activated protein kinase kinase (MAP2K/MEK) inhibitor, we identified genes whose expression is modulated by ERK1/2 pathway activity 6,7 .”
Self-citationDenley, S. M. (2008) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
PANCREATIC CARCINOGENESIS AND PROGRESSION
Furukawa, T. (2008) · Pancreas · doi:10.1097/01.mpa.0000325594.46227.55 · Cited by 1
Self-citationPancreatic carcinogenesis and progression
Furukawa, T. (2007) · Suizo · doi:10.2958/suizo.22.3 · Cited by 1
Self-citationNEURON SURVIVAL, AXON GROWTH AND THE TRANSCRIPTION FACTOR SRY-BOX CONTAINING GENE 11 (SOX11)
Jankowski, M. P. (2006) · D-Scholarship@Pitt (University of Pittsburgh)
Lentini, L., & Di, L. A. (2011) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/44443
Furukawa, T., Taki, K., & Ohmuraya, M. (2016) · Suizo · doi:10.2958/suizo.31.63
Self-citationStatistical Methods for the Analysis of Genomic Data
Jiang, H., & He, Z. (2020) · MDPI eBooks · doi:10.3390/books978-3-03936-141-0
Furukawa, T. (2007) · PubMed · Cited by 1
Self-citation刘, 彤., 王, 国., 于, 秉., 许, 琳., 张, 杰., 韩, 峰., & 宗, 志. (2012) · Scientia Sinica Vitae · doi:10.1360/zc2012-42-1-37
Ruckert, M. T. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2022.tde-09112022-122218
Dry, J. R., Pavey, S. J., Pratilas, C. A., Harbron, C. G., Runswick, S. K., Hodgson, D., Chresta, C. M., McCormack, R., Byrne, N., Cockerill, M. J., et al. (2023) · doi:10.1158/0008-5472.22386764.v1
Data from Validation of TPX2 as a Potential Therapeutic Target in Pancreatic Cancer Cells
Warner, S. L., Stephens, B. J., Nwokenkwo, S., Hostetter, G. H., Sugeng, A., Hidalgo, M. M., Trent, J. M., Han, H., & Hoff, D. D. V. (2023) · doi:10.1158/1078-0432.c.6517666
Zhang, Q., Tang, Y., Sun, S., Xie, Q., Yao, J., Wang, X., Qian, J., & Li, Z. (2024) · Figshare · doi:10.6084/m9.figshare.26554088
Samimi, H., Tavakoli, R., Fallah, P., Sohi, A. N., Shirkouhi, M. A., Naderi, M., & Haghpanah, V. (2024) · Figshare · doi:10.6084/m9.figshare.26551726
Zhang, Q., Tang, Y., Sun, S., Xie, Q., Yao, J., Wang, X., Qian, J., & Li, Z. (2024) · Figshare · doi:10.6084/m9.figshare.26554091
Zhang, Q., Tang, Y., Sun, S., Xie, Q., Yao, J., Wang, X., Qian, J., & Li, Z. (2024) · Figshare · doi:10.6084/m9.figshare.26554097
Zhang, Q., Tang, Y., Sun, S., Xie, Q., Yao, J., Wang, X., Qian, J., & Li, Z. (2024) · Figshare · doi:10.6084/m9.figshare.26554094
Rôle du corégulateur transcriptionnel RIP140 dans la signalisation par les facteurs E2Fs
Docquier, A. (2010) · theses.fr (ABES) · doi:10.70675/64f8d2cdzd236z48fdz8294z6cfdebdb2fd9
Kirsch, A. (2020) · theses.fr (ABES) · doi:10.70675/61d0cd26zd1d6z43e2z8902zefa16c42e651 · Cited by 2
Etude de l’hétérogénéité inter-tumorale et intra-tumorale des gliomes de haut grade
Picart, T. (2023) · theses.fr (ABES) · doi:10.70675/44510c06z2899z4b89zbd23z2e76f50cb0da
Patil, K., Boezi, A., Zvidzai, T., Ma, J., Dufek, G. A., Akbari, S., & Pai, S. B. (2026) · Scientific Reports · doi:10.1038/s41598-026-66894-3
Kumari, P., & Tengli, A. (2026) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2026.107663
Metadata
- Authors
- Furukawa, T., Kanai, N., Shiwaku, H. O., Soga, N., Uehara, A., & Horii, A.
- Affiliations
- Tokyo Women's Medical University (JP)
- Tohoku University (JP)
- Corresponding author
- Furukawa, T
- Venue
- Oncogene
- Published
- 2006-03-13
- Volume
- 25
- Issue
- 35
- Pages
- 4831-4839
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2048245178
- Cited by
- 135
- References
- 50
- Citations by year
- 2026: 1 · 2025: 8 · 2024: 6 · 2023: 9 · 2022: 10 · 2021: 9 · 2020: 6 · 2019: 5 · 2018: 8 · 2017: 4 · 2016: 8 · 2015: 4 · 2014: 8 · 2013: 4 · 2012: 6
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pancreas Research Foundation of Japan
- Foundation for Promotion of Cancer Research
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- AURKA, pancreatic cancer, KRAS mutation, ETS2, downstream target genes, mitosis, gene expression profiling, promoter activity, TPX2, CENP-A
- MeSH terms
- Cell Line, Cell Line, Transformed, Humans, Pancreatic Neoplasms, Gene Expression Regulation, Neoplastic, Protein Tyrosine Phosphatases, Protein Serine-Threonine Kinases, Mitogen-Activated Protein Kinase 1, Gene Expression Profiling, MAP Kinase Signaling System, Cell Line, Tumor, Dual Specificity Phosphatase 6, Aurora Kinase A, Aurora Kinase B, Aurora Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.